PNC Financial Services Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Buy
69,114
+10,544
+18% +$163K ﹤0.01% 1152
2025
Q1
$871K Sell
58,570
-139
-0.2% -$2.07K ﹤0.01% 1222
2024
Q4
$777K Buy
58,709
+3,392
+6% +$44.9K ﹤0.01% 1278
2024
Q3
$787K Buy
55,317
+176
+0.3% +$2.5K ﹤0.01% 1275
2024
Q2
$714K Sell
55,141
-13,419
-20% -$174K ﹤0.01% 1292
2024
Q1
$952K Sell
68,560
-3,172
-4% -$44.1K ﹤0.01% 1177
2023
Q4
$1.02M Sell
71,732
-255,384
-78% -$3.64M ﹤0.01% 1115
2023
Q3
$5.06M Sell
327,116
-4,148
-1% -$64.2K ﹤0.01% 625
2023
Q2
$5.2M Sell
331,264
-17,372
-5% -$273K ﹤0.01% 627
2023
Q1
$5.75M Sell
348,636
-7,085
-2% -$117K 0.01% 604
2022
Q4
$5.55M Sell
355,721
-10,786
-3% -$168K 0.01% 609
2022
Q3
$4.76M Buy
366,507
+27,286
+8% +$354K 0.01% 624
2022
Q2
$4.76M Sell
339,221
-32,175
-9% -$452K ﹤0.01% 646
2022
Q1
$5.32M Sell
371,396
-30,315
-8% -$434K ﹤0.01% 663
2021
Q4
$5.48M Sell
401,711
-48,403
-11% -$660K ﹤0.01% 674
2021
Q3
$7.37M Buy
450,114
+1,968
+0.4% +$32.2K 0.01% 563
2021
Q2
$7.54M Buy
448,146
+10,887
+2% +$183K 0.01% 561
2021
Q1
$7.99M Sell
437,259
-5,452
-1% -$99.6K 0.01% 538
2020
Q4
$8.06M Sell
442,711
-439
-0.1% -$7.99K 0.01% 516
2020
Q3
$7.91M Sell
443,150
-29,158
-6% -$520K 0.01% 502
2020
Q2
$8.47M Sell
472,308
-80,868
-15% -$1.45M 0.01% 475
2020
Q1
$8.4M Sell
553,176
-21,084
-4% -$320K 0.01% 441
2019
Q4
$11.3M Buy
574,260
+1,949
+0.3% +$38.5K 0.01% 441
2019
Q3
$9.84M Sell
572,311
-33,725
-6% -$580K 0.01% 496
2019
Q2
$10.7M Sell
606,036
-5,319
-0.9% -$94.1K 0.01% 502
2019
Q1
$12.5M Buy
611,355
+320,650
+110% +$6.53M 0.01% 466
2018
Q4
$4.89M Buy
+290,705
New +$4.89M 0.01% 685
2015
Q1
Sell
-318
Closed -$7K 4753
2014
Q4
$7K Buy
+318
New +$7K ﹤0.01% 3458